Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LaseRF Trial: Radiofrequency Ablation vs. Laser Hemorrhoidoplasty Procedure for Grade II-III Hemorrhoidal Disease: Prospective Randomised Controlled Trial

NCT04981600 is registered in ClinicalTrials.gov with Umraniye Education and Research Hospital as lead sponsor.

NCT NCT04981600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04981600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LaseRF Trial: Radiofrequency Ablation vs. Laser Hemorrhoidoplasty Procedure for Grade II-III Hemorrhoidal Disease: Prospective Randomised Controlled Trial
Lead sponsor
Umraniye Education and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2021
Completion date
April 1, 2023
Enrollment
92 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoids